A Short-Term Cost-of-Treatment Model for Type 2 Diabetes: Comparison of Glipizide Gastrointestinal Therapeutic System, Metformin, and Acarbose

August 1, 1999

Joe W. Ramsdell, MD

Joe W. Ramsdell, MD

, Joseph A. Grossman, MD

Joseph A. Grossman, MD

, Jennifer M. Stevens, PharmD

Jennifer M. Stevens, PharmD

, Marc F. Botteman, MSc, MA

Marc F. Botteman, MSc, MA

, Raul Arocho, PhD

Raul Arocho, PhD

Volume 5, Issue 8